Late Breaking Abstract - Phase 1 dose escalation study of aerosolized pirfenidone in normal healthy volunteers (NHV), smokers, and IPF patients
用户dO6Bp_vxHIqQ
1小时前
108
10
已关闭
DOI: 10.1183/13993003.congress-2018.oa266
文献链接: https://publications.ersnet.org/lookup/doi/10.1183/13993003.congress-2018.OA266
其他信息:
出版社: European Respiratory Society
作者: Alan Montgomery; Kelly Otto; Jun Khoo; Ian Glaspole

